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Abstract: Exposure to stray neutrons increases the risk of second cancer development after
proton therapy. Previously reported analytical models of this exposure were difficult to
configure and had not been investigated below 100 MeV proton energy. The purposes of this
study were to test an analytical model of neutron equivalent dose per therapeutic absorbed
dose (𝐻/𝐷) at 75 MeV and to improve the model by reducing the number of configuration
parameters and making it continuous in proton energy from 100 to 250 MeV. To develop the
analytical model, we used previously published H/D values in water from Monte Carlo
simulations of a general-purpose beamline for proton energies from 100 to 250 MeV. We also
configured and tested the model on in-air neutron equivalent doses measured for a 75 MeV
ocular beamline. Predicted H/D values from the analytical model and Monte Carlo agreed
well from 100 to 250 MeV (10% average difference). Predicted H/D values from the analytical
model also agreed well with measurements at 75 MeV (15% average difference). The results
indicate that analytical models can give fast, reliable calculations of neutron exposure after
proton therapy. This ability is absent in treatment planning systems but vital to second cancer
risk estimation.
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1. Introduction
In many cases, proton therapy is dosimetrically advantageous compared to other forms of external beam
radiation therapy because it allows for uniform target coverage with lower doses to healthy tissues [1–3].
However, proton therapy patients are still exposed to stray radiation, which is not fully understood and
not routinely estimated for most patients. Most proton beam treatments are delivered by the passive
scattering technique. Stray radiation dose to the patient from passively scattered proton therapy (PSPT)
primarily comes from neutrons that leak out of the treatment head [4,5]. This is a concern because
neutrons have an enhanced relative biological effectiveness compared with protons [6,7], and even
relatively small doses far from the primary treatment field increase the risk of secondary cancers [8].
Commercial treatment planning systems do not take neutron dose into account. Researchers have relied
mainly on measurements and Monte Carlo-based simulation in order to learn more about neutron exposures.
However, the time required for these methods is a barrier to research and routine clinical use. Thus, there
is a need for fast, accurate analytical models of leakage neutron equivalent dose from proton therapy.
Polf and Newhauser [9] reported that analytical models of neutron equivalent dose from proton
therapy are feasible. One proposed analytical model employed a power law to predict neutron equivalent
dose per therapeutic dose (𝐻/𝐷) for passively scattered proton therapy for different field sizes and
locations within a treatment vault [10,11]. This model was refined for 250 MeV pristine proton beams,
both in-air and in a water phantom, by Zhang et al. [12]. Anferov [13] reported a model based on
shielding calculation methods to predict the equivalent dose from neutrons for 100, 150, and 200 MeV proton
beams. The most compete and realistic leakage model to date was reported by Perez-Andujar et al. [14],
which takes into account four separate neutron energy regimes to predict 𝐻/𝐷 in-air and in-water for
proton beams with energies between 100 and 250 MeV. The model was found to have good agreement
when compared with benchmarked Monte Carlo simulations. However, this model was not continuous
with proton beam energy and required interpolation of parameters between the discrete energies
considered. The model’s large number of parameters made its configuration and use difficult. Furthermore,
the model was not compared with measured data nor was it tested at proton beam energies below 100 MeV.
The purpose of this study was to improve an analytical model of neutron 𝐻/𝐷 by making it
continuous in energy and reducing the number of free parameters, thus simplifying its configuration and
use. We compared the results of this model with Monte Carlo simulated neutron 𝐻/𝐷 values between
100 and 250 MeV for a conventional proton therapy beamline. Additionally, we configured and tested a
version of the model with new 𝐻/𝐷 measurements at 75 MeV proton beam energy.
2. Methods
2.1. Analytical Model
Building upon the methods of Perez-Andujar et al. [14], we improved an analytical model for 𝐻/𝐷
from leakage neutrons from passively scattered proton therapy. For the reader’s convenience, we briefly
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review the previous model here. 𝐻/𝐷 contributions are calculated from four neutron energy regimes:
intranuclear cascade neutrons (also called direct neutrons), evaporation neutrons, epithermal neutrons
(also called 1/𝐸 neutrons), and thermal neutrons. Cascade neutrons are produced when a bombarding
proton interacts with a target nucleus and can have energies up to the maximum energy of the proton
beam. The second highest energy regime, that of evaporation neutrons, corresponds to neutrons ejected
by the excited nucleus after the initial proton collision in processes known as compound emission and
pre-equilibrium emission. The third energy regime, epithermal neutrons, corresponds to neutrons that
have lost some portion of their energy via inelastic scattering and moderation. Some of these neutrons
will be lost via capture processes. Finally, the lowest energy regime corresponds to thermal neutrons that
have lost most of their kinetic energy and are in thermal equilibrium with the environment. These
undergo elastic scattering until they are eventually captured.
The analytical model for 𝐻/𝐷 at a point, 𝑝, in a water phantom is
4

2
𝐻
𝐻
𝑑 −𝑞
−(𝑥 2 + 𝑦 2 )𝑑𝑖𝑠𝑜
′
)] exp [
( ) =( )
(
) ∑ 𝐶𝑖 (𝐸) exp[−𝛼𝑖 (𝑑 ′ − 𝑑𝑖𝑠𝑜
]
𝐷 𝑝
𝐷 𝐸,𝑖𝑠𝑜 𝑑𝑖𝑠𝑜
2𝜎𝑖2 𝑧 2

(1)

𝑖=1

where (𝐻/𝐷)𝐸,𝑖𝑠𝑜 is the total neutron equivalent dose per treatment dose at isocenter as a function of the
proton beam energy; 𝑑 is the distance from the neutron source to the calculation point; 𝑑 ′ is the distance
along the ray, 𝑑, from the phantom surface to the calculation point; 𝑑𝑖𝑠𝑜 is the distance from the neutron
′
source to isocenter; and 𝑑𝑖𝑠𝑜
is the distance along the ray, 𝑑𝑖𝑠𝑜 , from the phantom surface to isocenter.
The irradiation geometry, dimensions, and distances are shown in Figure 1. The exponent, 𝑞, governs
the power law falloff of neutron dose with distance from isocenter. The 𝐶𝑖 (𝐸) terms apportion the
fraction of the total equivalent dose resulting from the each of the four neutron energy regimes. The first
exponential term models neutron attenuation in the phantom. The mean free paths of the neutrons of the
𝑖𝑡ℎ regime in water are denoted by 𝛼𝑖 , with the first exponential term modeling neutron attenuation in
the phantom. The second exponential term, then, models the lateral distribution of the 𝑖𝑡ℎ neutron regime
with 𝜎𝑖 as the Gaussian width parameter.

Figure 1. Geometry of a general-purpose proton treatment head and water phantom. Adapted
from Perez-Andujar et al. [14].

Cancers 2015, 7

798

In this work, several improvements have been made to the model. Previously, the model required
interpolation of (𝐻/𝐷)𝑖𝑠𝑜 values at proton beam energies between energies contained in the lookup
tables. In this work, (𝐻/𝐷)𝐸,𝑖𝑠𝑜 has been parameterized with proton beam energy according to a power
law relationship, or
𝐻
𝐻
= 𝛼𝐸 × 𝐸 𝑝𝐸 × ( )
( )
𝐷 𝐸,𝑖𝑠𝑜
𝐷 𝑟𝑒𝑓,𝑖𝑠𝑜

(2)

where (𝐻/𝐷)𝑟𝑒𝑓,𝑖𝑠𝑜 is the neutron equivalent dose value at isocenter for a proton beam of a given
reference energy (100 MeV in this study), 𝑝𝐸 is the exponent governing the power law, 𝛼𝐸 is a scaling
factor, and 𝐸 is the proton beam energy. This value may be obtained from measurement or from a Monte
Carlo simulation and is found by taking the quotient
(𝐻/𝑝)𝑐𝑙𝑜𝑠𝑒𝑑
𝐻
𝑟𝑒𝑓,𝑖𝑠𝑜
=
( )
𝐷 𝑟𝑒𝑓,𝑖𝑠𝑜 (𝐷/𝑝)𝑜𝑝𝑒𝑛
𝑟𝑒𝑓,𝑖𝑠𝑜

(3)

𝑜𝑝𝑒𝑛

where (𝐷/𝑝)𝑟𝑒𝑓,𝑖𝑠𝑜 is the absorbed dose in gray per proton at isocenter found with the collimator open
and (𝐻/𝑝)𝑐𝑙𝑜𝑠𝑒𝑑
𝑟𝑒𝑓,𝑖𝑠𝑜 is the neutron equivalent dose in sievert per proton with the collimator closed [11].
The previous model relied on lookup tables of 32 𝐶𝑖 values that were found from an iterative fitting
process; four values at each of the eight proton beam energies considered from 100 to 250 MeV [14]. In the
improved model, the 𝐶𝑖 (𝐸) values that apportion the contributions from each neutron regime were
parameterized as functions of proton beam energy. Specifically, for intranuclear cascade neutrons, we
use the linear form
𝐶1 (𝐸) = 𝑎1 𝐸 + 𝑏1

(4)

where 𝐸 is the proton beam energy, 𝑎1 is the slope, and 𝑏1 is the intercept. For evaporation neutrons, the
cumulative normal was used with a lower bound as in,
𝐶2 (𝐸) = 𝑎2 cnorm(𝐸, 𝑏2 , 𝑐2 ) + 𝑑2

(5)

where 𝑎2 is a scaling coefficient, 𝑑2 is the lower bound, and the cumulative normal function with mean
value 𝑏2 and width parameter 𝑐2 is defined in the usual way as
cnorm(𝐸, 𝑏2 , 𝑐2 ) =

𝐸

−(𝐸 ′ − 𝑏2 )2
∫ exp [
] 𝑑𝐸′
2𝑐22
𝑐2 √2𝜋 −∞
1

(6)

The epithermal regime was modeled as
𝐶3 (𝐸) = 𝑎3

(7)

where 𝑎3 is a constant. For the thermal neutrons, we used
𝐶4 (𝐸) = 𝑎4 𝐸 2 + 𝑏4 𝐸 + 𝑐4

(8)

where 𝑎4 , 𝑏4 , and 𝑐4 are the polynomial’s second, first, and zeroth order coefficients. Since these curves are
used to apportion the equivalent dose from each neutron energy regime, they were constrained so that
their sum is unity. The forms of Equations (4)–(8) were chosen empirically to faithfully reproduce the
shapes of the 𝐶 curves with energy while simultaneously reducing the number of model parameters.
Specifically, the approach of Perez-Andujar et al. [14] required a lookup table containing 40 values plus
9 energy independent parameters for a total of 49 parameters. Our model requires only 13 values plus
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9 energy independent parameters for a total of 22 parameters to cover the same interval of proton beam
energies from 100 to 250 MeV. Parameterizing these terms with energy offers several advantages
compared with the table lookup. It allows the model to be continuous in energy and reduces the number
of free parameters. The values for the parameters 𝛼𝐸 , 𝑝𝐸 , 𝑎1 , 𝑏1 , 𝑎2 , 𝑏2 , 𝑐2 , 𝑑2 , 𝑎3 , 𝑎4 , 𝑏4 , and 𝑐4 were
obtained via the iterative fitting process described in Section 2.4 below.
2.2. Monte Carlo Simulated 𝐻/𝐷 Values for General Purpose Beamline at 100 to 250 MeV
Previous studies [12,14] utilized dosimetric data exclusively from Monte Carlo simulations to
develop the model. In this study, we purposefully utilized the same Monte Carlo data in order to facilitate
the comparison of results with and without the improvements developed in this work. The Monte Carlo
data were taken from a simulation of the passive scattering system in place at The University of Texas
MD Anderson Cancer Center described in detail by Perez-Andujar et al. [14]. This was accomplished
with the Monte Carlo Proton Radiotherapy Treatment Planning (MCPRTP) system [15] which utilizes
the Monte Carlo N-Particle eXtended (MCNPX) Radiation Transport Code [16]. MCNPX is commonly used
for simulating neutron exposures and has been extensively benchmarked against measurements [17–22].
Simulations were carried out first with an open collimator to determine the primary absorbed dose per
proton, 𝐷/𝑝. Next, simulations were done with a closed final collimator to determine the neutron equivalent
dose per proton, 𝐻/𝑝, and the ratio of these yields 𝐻/𝐷. The simulated neutron data includes nominal
proton beam energies of 100, 120, 140, 160, 180, 200, 225, and 250 MeV with a closed collimator,
pristine Bragg peak, and with the proton beam incident on a water phantom. The phantom contained 100
spherical detecting volumes, each of 1 cm diameter. The detecting volumes were located along lines
parallel to the beam axis at 0 cm, 10 cm, 40 cm, and 80 cm off-axis, as well as one line perpendicular to
the beam axis at the depth of isocenter in the phantom (22 cm). The simulation geometry is illustrated
in Figure 1.
2.3. Measured 𝐻/𝐷 for Ocular Beamline at 75 MeV
Measurements of 𝐻/𝐷 for the 75 MeV proton beam were carried out at Centre de Proton thérapie
d’Orsay (CPO) in France in a single-scattering proton beamline dedicated to ocular tumor treatments.
During the neutron measurements, a closed patient collimator was used together with a pristine Bragg
peak. We selected 75 MeV proton beam energy because it is representative of ocular treatments at CPO.
Measurements were taken in air.
Two instrument types were used to acquire neutron ambient dose equivalent, 𝐻 ∗ (10), in air. The Berthold
LB 6411 [23] is a conventional neutron probe with a spherical polyethylene moderator (25 cm external
diameter) and a central 3He proportional counter (4 cm external diameter and 10 cm length). It is known
to be suitable for ambient dose equivalent measurements in the energy range from thermal to 20 MeV [24].
Additionally, this rem-counter is characterized by a high rejection coefficient for gamma radiation. The
WENDI-II is a survey meter with a cylindrical polyethylene moderator (22.9 cm in diameter and 21 cm
long), and a central cylindrical 3He proportional counter [25]. The moderator encloses a tungsten powder
shell of 1.5 cm thickness, which enhances the accuracy of the instrument’s response at energies above
about 20 MeV by neutron multiplication.
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The measurements of 𝐻 ∗ (10) were made at isocenter and several distances from isocenter along the
proton beam axis and 45°and 90°with respect to the beam axis. Figure 2 shows the ocular beamline and
the 10 measurement positions.

Figure 2. Geometry of a proton therapy system for ocular treatments and positioning of the
neutron equivalent dose meters along the three axes at 0°, 45°and 90°with respect to the
proton beam direction.
2.4. Model Training
Previously, the model was trained separately at each proton beam energy considered [14]. In this
work, we trained the improved model for the general-purpose beamline by fitting to all data from 100 to
250 MeV simultaneously. All free parameters were selected using the generalized reduced gradient
method to minimize the local relative differences in 𝐻/𝐷 [26].
The model was trained separately for the 75 MeV measurements. This was necessary because of the
considerable differences between the beamlines. Because the measured data from the ocular beamline
consist of a single proton beam energy and measurements were taken in air, some modifications were
necessary. The 𝛼𝑖 terms from Equation (1), which model neutron attenuation in water, were defined to
be zero since there is no water present. The power law model for (𝐻/𝐷)𝐸,𝑖𝑠𝑜 in Equation (2) was simply
replaced with the measured 𝐻/𝐷 value at isocenter at 75 MeV. Finally, the 𝐶𝑖 (𝐸) curves defined in
Equations (4)–(8) were replaced with scalar coefficients 𝐶1 , 𝐶2 , 𝐶3 , and 𝐶4 .
3. Results
3.1. Model Agreement with Monte Carlo Data at 100 to 250 MeV
Figure 3 shows the Monte Carlo simulated and analytical model calculated values of 𝐻/𝐷 at isocenter
for the general-purpose beamline. 𝐻/𝐷 along the central axis is plotted as a function of depth in water
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for all energies in Figure 4. Figures 5–7 plot the corresponding results at off-axis distances of 10 cm, 40 cm,
and 80 cm, respectively. Figure 8 shows lateral 𝐻/𝐷 profiles for all energies at isocenter depth (22 cm).
These figures demonstrate the good agreement between the 𝐻/𝐷 values from Monte Carlo simulations
and the analytical model calculations. The average relative difference between the analytical model and
the Monte Carlo calculations at all proton beam energies and locations considered was 10% with a
maximum difference of 60%. The maximum difference occurred for the 120 MeV proton beam energy
at a location 80 cm off-axis and 19 cm deep in the phantom.

(H/D)iso (mSv/Gy)

6

Ocular beam-line
Gen. purpose beam-line
Analytical model

5
4
3
2
1
0
0

75

100

125

150

175

200

225

250

E (MeV)

Figure 3. (𝐻/𝐷)𝑖𝑠𝑜 values versus proton beam energy, E. Ocular beamline value (×) was
measured in-air. General-purpose beamline values (circles) were obtained from Monte Carlo
simulations. Analytical model (line) values were calculated using Equation (2).
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Figure 4. Predictions from Monte Carlo (points) and analytical model (lines) of neutron
equivalent dose per treatment dose (𝐻/𝐷) values versus depth in water from proton beams
for 100, 120, 140, 160, 180, 200, 225, and 250 MeV.
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Figure 5. Predictions from Monte Carlo (points) and analytical model (lines) of neutron
equivalent dose per treatment dose (𝐻/𝐷) versus depth in water at 10 cm off-axis for 100 to
250 MeV proton beam energies.
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Figure 6. Predictions from Monte Carlo (points) and analytical model (lines) of neutron
equivalent dose per treatment dose (𝐻/𝐷) versus depth in water at 40 cm off-axis for 100 to
250 MeV proton beam energies.
The parameters governing (𝐻/𝐷)𝐸,𝑖𝑠𝑜 from (2) are shown in Table 1. Table 2 lists the parameters that
govern the 𝐶𝑖 (𝐸) curves in Equations (4)–(7). Our results confirm the findings of Perez-Andujar et al. [14]
that the largest contribution to 𝐻/𝐷 is from the high-energy direct neutrons followed by the epithermal
neutrons. 𝐻/𝐷 from the evaporation neutron regime is more prevalent at higher energies, and the thermal
neutron regime contributes a relatively small component of the equivalent dose. Figure 9 shows the
𝐶𝑖 (𝐸) curves from this work plotted with proton beam energy and compared with analogous values from
Perez-Andujar et al. [14]. Use of the parameterized 𝐶𝑖 (𝐸) curves greatly reduced the difficulty of
configuring the model by preventing non-physical fluctuations of several parameters with energy,
eliminating the need for subjective manual adjustments.
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Figure 7. Predictions from Monte Carlo (points) and analytical model (lines) of neutron
equivalent dose per treatment dose (𝐻/𝐷) versus depth in water at 80 cm off-axis for 100 to
250 MeV proton beam energies.
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Figure 8. Predictions from Monte Carlo (points) and analytical model (lines) of neutron
equivalent dose per treatment dose (𝐻/𝐷) versus off-axis position at 22 cm depth in water
for 100 to 250 MeV proton beam energies.
Table 1. Parameters for power law relationship for (𝐻/𝐷)𝐸,𝑖𝑠𝑜 .
𝜶𝑬
8.0 × 10−9

𝒑𝑬
4.1 × 100

(𝑯/𝑫)𝟏𝟎𝟎,𝒊𝒔𝒐 (Sv/Gy)
1.2 × 10−4

Table 2. Parameters for 𝐶𝑖 (𝐸) equations to apportion equivalent dose from neutron energy regimes.
Neutron Energy Regime
Intranuclear Cascade
Evaporation
Epithermal
Thermal

𝒂𝒊
−4.8 × 10−4
1.2 × 10−1
4.0 × 10−1
1.2 × 10−7

𝒃𝒊
6.0 × 10−1
1.3 × 102
N/A
−6.6 × 10−5

𝒄𝒊
N/A
5.0 × 100
N/A
1.1 × 10−2

𝒅𝒊
N/A
−1.3 × 10−11
N/A
N/A

C4 (Thermal) C3 (1/E)

C2 (Evap) C1 (Direct)
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Perez-Andujar
This work (Refit)
This work (Final)

6.0*10-1
4.5*10-1
3.0*10-1
1.5*10-1
0
2.0*10-1
1.5*10-1
1.0*10-1
5.0*10-2
0
6.0*10-1
4.5*10-1
3.0*10-1
1.5*10-1
0
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4.5*10-3
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1.5*10-3
0
100
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180

200

225
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Figure 9. Plot of 𝐶𝑖 values for each neutron energy regime versus proton beam energy.
Points represent 𝐶𝑖 values from Perez-Andujar et al. [14] (circles) and from a refitting of that
model using the improved fitting methods (squares). The solid curves represent the
parameterized 𝐶𝑖 (𝐸) models used in the final version.
Table 3 lists the energy independent parameters, including the neutron attenuation factors and Gaussian
width parameters. As expected, the width parameters for the low energy neutron regimes, epithermal
and thermal, are very large corresponding to an isotropic distribution. The higher energy neutron regimes
are forward peaked. The exponent governing falloff, 𝑞, was found to be 1.13. Table 4 lists a comparison
of the accuracies for all locations and all energies, as well as at each specific energy, between this work
and Perez-Andujar et al. [14]. We found similar agreement with the Monte Carlo simulations. The average
local relative differences were within 4% of each other for all energies. The maximum local relative
error was decreased from 76% to 60%.
Table 3. Neutron attenuation parameters and Gaussian width parameters for the four neutron regimes.
Direct
𝜶𝟏 (cm ) 𝝈𝟏 (cm)
1.3 × 10−2 1.4 × 101
−1

Evaporation
𝜶𝟐 (cm−1) 𝝈𝟐 (cm)
1.3 × 10−2 7.7 × 101

Epithermal
𝜶𝟑 (cm−1) 𝝈𝟑 (cm)
3.2 × 10−2 3.9 × 103

Thermal
𝜶𝟒 (cm−1) 𝝈𝟒 (cm)
3.3 × 10−1 3.9 × 103

3.2. Model Agreement with Measured Data at 75 MeV
Measured and calculated 𝐻/𝐷 values for the ocular beamline data are shown in Figure 10 with separate
plots for each of the rays measured along: 0°, 45°, and 90°with respect to the beam axis. The plot shows
good agreement between measured values and the analytical model. We conservatively estimated the
uncertainty in the measured data at ±25%, and the calculated 𝐻/𝐷 values agreed within this limit for all
points considered. The average error was 16% and the maximum error was 24%. The exponent that governs
falloff, 𝑞, was found to be 1.5. The larger 𝑞 value is expected in this instance since the ocular beamline
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is narrower and should more closely resemble a point source. The parameters 𝐶1 − 𝐶4 , 𝜎1 − 𝜎4 , and
𝐻/𝐷𝑖𝑠𝑜 for the ocular beamline data are listed in Table 5.
Table 4. Average local relative error (𝛥̅) and maximum local relative error (𝛥|max ) for the
analytical model of the general-purpose beamline from this work and Perez-Andujar et al. [14].
Proton Energy (MeV)
All
250
225
200
180
160
140
120
100

This Work
̅ (%)
𝜟
𝜟|𝐦𝐚𝐱 (%)
10
60
7
39
7
29
7
31
11
31
11
33
11
45
11
60
16
54

Perez-Andujar et al. [14]
̅ (%)
𝜟
𝜟|𝐦𝐚𝐱 (%)
10
76
7
30
6
29
6
34
7
34
10
45
10
46
15
61
18
76
Measured 0°
Calculated 0°

60
45
30
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Figure 10. Measured (circles) and calculated (lines) 𝐻/𝐷 values for the ocular beamline
plotted vs. distance from isocenter. The top plot shows data taken along the beam axis with
points distal to isocenter. The middle plot shows the values along a ray 45°with respect to
the beam axis. The lower plot shows values directly lateral to isocenter, i.e., along a ray 90°
with respect to the beam axis.
Table 5. Model parameters for ocular beamline.
𝑪𝟏
1.1 × 10

𝑪𝟐
−2

7.8 × 10

𝑪𝟑
−1

1.0 × 10

𝑪𝟒
−1

9.6 × 10

−2

𝝈𝟏 (𝒄𝒎)

𝝈𝟐 (𝒄𝒎)

𝝈𝟑 (𝒄𝒎)

𝝈𝟒 (𝒄𝒎)

0

3

3

3

9.4 × 10

1.0 × 10

4.2 × 10

4.2 × 10

(𝑯/𝑫)𝒊𝒔𝒐
(𝑺𝒗/𝑮𝒚)
5.2 × 10−5
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4. Discussion
We have improved an analytical model for predicting 𝐻/𝐷 from leakage neutrons for proton therapy
by parameterization of energy dependent aspects of the model, thereby reducing the number of free
parameters and simplifying the model configuration process. We have demonstrated the training of this
model using Monte Carlo simulated neutron exposures for proton beam energies from 100 to 250 MeV
and using measured data from a separate 75 MeV proton therapy beamline.
The major finding of this work is that an analytical model of neutron 𝐻/𝐷 for passively scattered
proton therapy may be applied continuously over a wide range of proton beam energies with relatively
fewer model parameters. In addition to reducing the number of free parameters, explicitly modeling the
contribution of different neutron energy regimes based on the proton beam energy yields other advantages
to our model. The model is now continuous in energy, and this approach obviates the need to interpolate
from a table of values at intermediate energies. The model can be easily applied to energies between those
used in the work without the need for additional measurements or crude linear interpolation. In contrast, the
lookup table approach employed by Perez-Andujar et al. [14] requires the interpolation of several parameters
for use at energies other than those contained in the lookup table and also requires a large number of
energy specific parameters that complicate the training of the model. Our method reduces the number of
free parameters, and our improved fitting methods have made the model training process much simpler
for the user. This approach gives confidence that the fitted parameters follow physically realistic
dependencies on proton beam energy and are not the result of over-fitting or memorizing the data.
Another encouraging confirmatory finding is that the analytical model is applicable to low energy
proton beams such as those used in ocular treatments. It is important that the model be easily adaptable
to other passive scattering treatment systems, so that it can have the greatest possible impact and find
use at many different institutions. Importantly, Farah et al. [27] previously reported on the difficulty in
configuring the original model, an obstacle that this work has successfully overcome.
The results of this work are consistent with the findings of other studies. Perez-Andujar et al. [14]
found that to accurately model the equivalent dose from leakage neutrons requires the consideration of
no fewer than four neutron energy regimes. That is supported by this work. The contributions from each
of the four neutron energy regimes are similar for this work and the previous model. Furthermore, the
dosimetric accuracies were found to be similar.
A major strength of this study is that the improved model relies on far fewer free parameters than
previous works. The inclusion of measured data from a second passively-scattered proton therapy beamline
is another strength of this study. Specifically, the analytical model was configured for use at the lower
energy (75 MeV) and compared against experimental data to validate its utility to predict stray radiation
from an ocular beamline.
One limitation of this study is that we only benchmarked the model with measured data at a single
proton beam energy for the ocular beamline. Additionally, the measured data was taken in-air and not in
a water phantom. These limitations are minor because we demonstrated good agreement for the model
compared with Monte Carlo simulated 𝐻/𝐷 values in a water phantom and at many different energies
for the general purpose beamline.
Future work on leakage radiation from proton therapy should include research and development to
translate the analytical models to clinical practice. Specifically, the model should be integrated into
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treatment planning systems to facilitate routine clinical dose assessments for patients with heterogeneous
anatomy and irregular external surfaces. A study from our group has yielded promising preliminary
results indicating that the integration of a similar analytical model into a radiotherapy treatment planning
system is technically feasible and the leakage-dose algorithm is sufficiently fast for routine clinical
treatment planning applications [28]. Specifically, this study found that the time required was a factor of
1.6 of the time necessary for the proton dose calculation allowing for the total calculation to be completed
in less than one hour on a single CPU. Additional research and development work will be needed to enhance
the analytical model to account for other treatment factors such as range modulation. Range modulation
can be modeled from first principles using the proton modulation function including proton fluence
weights, Equations (2)–(5) from Polf and Newhauser [9] or Equations (1)–(4) from Zheng et al. [29],
and dosimetric data at multiple proton beam energies from Monte Carlo simulations. If the relationship
between 𝐻/𝐷 and the modulation width is known from measurements or simulations of the usual case
with flat-topped Bragg peaks, the dependence of 𝐻/𝐷 on modulation width may be accounted for with
an empirical analytical model. From previous work, we know that 𝐻/𝐷 increases with modulation width
modestly and continuously (see Figure 9 in Zheng et al. [29]), and it appears to follow a simple analytic
expression, e.g., a polynomial or asymptotic exponential function. Studies on range modulation and other
treatment factors are underway in our laboratory. This model may also find application for scanned-beam
proton therapy beamlines equipped with passive and dynamic collimators, e.g., milled brass collimators,
multi-leaf collimators [30,31], and trimmers [32].
5. Conclusions
In this work, we improved an analytical model of neutron 𝐻/𝐷 for passively scattered proton therapy
in the energy range from 100 to 250 MeV. The improved model relies on fewer configuration parameters
and is easier to train. We tested the analytical model on measured neutron 𝐻/𝐷 values from a separate
75 MeV beamline. Our results revealed good agreement of the model with both measured data and Monte
Carlo simulations. The results of this work suggest that, with further development and testing, analytical
models may be applicable for routine use in clinical treatment planning systems to predict neutron
exposures to patients.
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